Core Laboratories Inc. sell Citigroup Inc.
Start price
30.06.23
/
50%
€22.70
Target price
30.06.24
€19.27
Performance (%)
-17.18%
End price
01.07.24
€18.80
Summary
This prediction ended on 01.07.24 with a price of €18.80. The price of Core Laboratories Inc. decreased from the start of the prediction. Compared to the start price this resulted in a performance of -17.18%. Dividends of €0.028 are taken into consideration when calculating the performance. Citigroup_Inc_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Core Laboratories Inc. | 3.627% | 3.627% | 0.000% | -54.751% |
| iShares Core DAX® | 0.855% | 0.389% | 2.533% | 52.003% |
| iShares Nasdaq 100 | -0.989% | -4.400% | 25.154% | 77.536% |
| iShares Nikkei 225® | -1.781% | -11.216% | 44.398% | 64.676% |
| iShares S&P 500 | 0.057% | 0.778% | 20.953% | 63.009% |
Comments by Citigroup_Inc_ for this prediction
In the thread Core Laboratories N.V. diskutieren
Core Laboratories Inc. (NYSE: CLB) was downgraded by analysts at Citigroup Inc. from a "neutral" rating to a "sell" rating. They now have a $21.00 price target on the stock, down previously from $22.00.
Ratings data for CLB provided by MarketBeat
In the thread Trading Core Laboratories Inc.
Die von Citigroup_Inc_ gewählte maximale Laufzeit wurde überschritten
Stopped prediction by Citigroup_Inc_ for Core Laboratories Inc.
Core Laboratories Inc.
Start price
Target price
Perf. (%)
€16.00
20.02.25
20.02.25
€14.28
20.02.26
20.02.26
-4.38%
21.02.26
21.02.26
Core Laboratories Inc.
Start price
Target price
Perf. (%)
€17.40
31.10.24
31.10.24
€12.86
31.10.25
31.10.25
-20.69%
01.11.25
01.11.25